119 related articles for article (PubMed ID: 26676787)
1. Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics.
Lai KK; Cheung NN; Yang F; Dai J; Liu L; Chen Z; Sze KH; Chen H; Yuen KY; Kao RY
J Virol; 2015 Dec; 90(5):2690-701. PubMed ID: 26676787
[TBL] [Abstract][Full Text] [Related]
2. Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
Kitamura S; Lin TH; Lee CD; Takamura A; Kadam RU; Zhang D; Zhu X; Dada L; Nagai E; Yu W; Yao Y; Sharpless KB; Wilson IA; Wolan DW
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2310677121. PubMed ID: 38753503
[TBL] [Abstract][Full Text] [Related]
3. Vitamin derivatives as potential drugs for Influenza Hemagglutinin.
Agrawal A; Chanana P; Yadav V; Bhutani V; Subbarao N; Srivastava A
J Biomol Struct Dyn; 2023; 41(21):11781-11795. PubMed ID: 36629034
[TBL] [Abstract][Full Text] [Related]
4. Computation of Hemagglutinin Free Energy Difference by the Confinement Method.
Boonstra S; Onck PR; van der Giessen E
J Phys Chem B; 2017 Dec; 121(50):11292-11303. PubMed ID: 29151344
[TBL] [Abstract][Full Text] [Related]
5. A Single Mutation at PB1 Residue 319 Dramatically Increases the Safety of PR8 Live Attenuated Influenza Vaccine in a Murine Model without Compromising Vaccine Efficacy.
Cox A; Dewhurst S
J Virol; 2015 Dec; 90(5):2702-5. PubMed ID: 26676793
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activity.
Kathum OA; Schräder T; Anhlan D; Nordhoff C; Liedmann S; Pande A; Mellmann A; Ehrhardt C; Wixler V; Ludwig S
Cell Microbiol; 2016 Jun; 18(6):784-91. PubMed ID: 26687707
[TBL] [Abstract][Full Text] [Related]
7. The Interaction between Influenza HA Fusion Peptide and Transmembrane Domain Affects Membrane Structure.
Lai AL; Freed JH
Biophys J; 2015 Dec; 109(12):2523-2536. PubMed ID: 26682811
[TBL] [Abstract][Full Text] [Related]
8. Protein mutations following adaptation of avian influenza viruses in different biological systems.
Lombardo T; Chiapponi C; Baioni L; Cinotti S; Ferrari M
Res Vet Sci; 2015 Dec; 103():176-8. PubMed ID: 26679814
[TBL] [Abstract][Full Text] [Related]
9. Genetic characterization of highly pathogenic H5 influenza viruses from poultry in Taiwan, 2015.
Huang PY; Lee CD; Yip CH; Cheung CL; Yu G; Lam TT; Smith DK; Zhu H; Guan Y
Infect Genet Evol; 2016 Mar; 38():96-100. PubMed ID: 26690663
[TBL] [Abstract][Full Text] [Related]
10. Identification of Stabilizing Mutations in an H5 Hemagglutinin Influenza Virus Protein.
Hanson A; Imai M; Hatta M; McBride R; Imai H; Taft A; Zhong G; Watanabe T; Suzuki Y; Neumann G; Paulson JC; Kawaoka Y
J Virol; 2015 Dec; 90(6):2981-92. PubMed ID: 26719265
[TBL] [Abstract][Full Text] [Related]
11. European Academies Advise on Gain-of-Function Studies in Influenza Virus Research.
Fears R; ter Meulen V
J Virol; 2015 Dec; 90(5):2162-4. PubMed ID: 26699646
[TBL] [Abstract][Full Text] [Related]
12. Knowns and unknowns of influenza B viruses.
Koutsakos M; Nguyen TH; Barclay WS; Kedzierska K
Future Microbiol; 2016; 11(1):119-35. PubMed ID: 26684590
[TBL] [Abstract][Full Text] [Related]
13. A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose.
Dhanwani R; Zhou Y; Huang Q; Verma V; Dileepan M; Ly H; Liang Y
J Virol; 2015 Dec; 90(5):2551-60. PubMed ID: 26676795
[TBL] [Abstract][Full Text] [Related]
14. Amino Acid Substitutions That Affect Receptor Binding and Stability of the Hemagglutinin of Influenza A/H7N9 Virus.
Schrauwen EJ; Richard M; Burke DF; Rimmelzwaan GF; Herfst S; Fouchier RA
J Virol; 2016 Jan; 90(7):3794-9. PubMed ID: 26792744
[TBL] [Abstract][Full Text] [Related]
15. Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins.
Batra J; Tripathi S; Kumar A; Katz JM; Cox NJ; Lal RB; Sambhara S; Lal SK
Sci Rep; 2016 Jan; 6():19063. PubMed ID: 26750153
[TBL] [Abstract][Full Text] [Related]
16. The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses.
Pécheur EI; Borisevich V; Halfmann P; Morrey JD; Smee DF; Prichard M; Mire CE; Kawaoka Y; Geisbert TW; Polyak SJ
J Virol; 2016 Jan; 90(6):3086-92. PubMed ID: 26739045
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, genetics, and transmissibility in ferrets of Eurasian avian-like H1N1 swine influenza viruses.
Yang H; Chen Y; Qiao C; He X; Zhou H; Sun Y; Yin H; Meng S; Liu L; Zhang Q; Kong H; Gu C; Li C; Bu Z; Kawaoka Y; Chen H
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):392-7. PubMed ID: 26711995
[TBL] [Abstract][Full Text] [Related]
18. PB2-588 V promotes the mammalian adaptation of H10N8, H7N9 and H9N2 avian influenza viruses.
Xiao C; Ma W; Sun N; Huang L; Li Y; Zeng Z; Wen Y; Zhang Z; Li H; Li Q; Yu Y; Zheng Y; Liu S; Hu P; Zhang X; Ning Z; Qi W; Liao M
Sci Rep; 2016 Jan; 6():19474. PubMed ID: 26782141
[TBL] [Abstract][Full Text] [Related]
19. Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine.
Liu Z; Zhao J; Li W; Shen L; Huang S; Tang J; Duan J; Fang F; Huang Y; Chang H; Chen Z; Zhang R
Sci Rep; 2016 Jan; 6():19095. PubMed ID: 26754609
[TBL] [Abstract][Full Text] [Related]
20. Targeting host calpain proteases decreases influenza A virus infection.
Blanc F; Furio L; Moisy D; Yen HL; Chignard M; Letavernier E; Naffakh N; Mok CK; Si-Tahar M
Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L689-99. PubMed ID: 26747784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
